We support you at every stage of the process – from choosing the right API source and qualifying the manufacturer, through import and delivery logistics, to providing the required quality and regulatory documentation. Our experience in the international supply chain allows us to meet the needs of medicinal product manufacturers as well as other companies in the pharmaceutical sector.
Active substances
for the pharmaceutical industry
Import and distribution of active pharmaceutical ingredients (API) from Europe, the USA, South Korea, Japan, China and India.
We offer end-to-end services for the import, supply and distribution of active pharmaceutical ingredients (API) intended for the manufacture of human and veterinary medicinal products. We work with qualified manufacturers from Europe, the United States, South Korea, Japan, China and India, providing access to a broad portfolio of active substances across a range of therapeutic groups.
Our priority is a stable and secure source of API supply that meets the quality and regulatory requirements of the European market. Every manufacturer we start working with goes through a formal qualification process. It covers an assessment of the manufacturer’s capabilities, manufacturing standards, quality system, GMP compliance, and the availability and completeness of the documentation required for the given market.
| Substance name | Therapeutic group | CAS no. | Documentation | Country |
|---|---|---|---|---|
| 2-Aminoheptane Sulfate | Decongestant | 3595-14-0 | CEP | ITA |
| Metformina HCl | 1115-70-4 | CEPGMPWC | CN/EU | |
| Aciclovir | Anti-viral | 59277-89-3 | CEPDMF | IND |
| Amoksycylina trójwodna | 61336-70-7 | ASMFCEPGMP | CN | |
| Afoxolaner under development | Veterinary API | 1093861-60-9 | IND | |
| Ibuprofen | 15687-27-1 | CEPGMPWC | CN/EU | |
| Albuterol Sulfate | Anti-asthmatic | 51022-70-9 | DMFWC | IND |
| Paracetamol | 103-90-2 | CEPGMPWC | CN/EU | |
| Alfacalcidol | Vitamin analogue | 41294-56-8 | CEPDMF | POL |
| Omeprazol | 73590-58-6 | ASMFCEPGMP | CN/IN | |
| Alverine Citrate | Anti-spasmodic | 5560-59-8 | DMF | ITA |
| Atorwastatyna wapniowa | 344423-98-9 | ASMFCEPGMP | CN/IN | |
| Ammonium chloride | Mineral salt | 12125-02-9 | CEPDMF | ESP |
| Kwas acetylosalicylowy | 50-78-2 | CEPGMP | EU/CN | |
| Anastrozole | Anti-cancer | 120511-73-1 | DMF | POL |
| Diklofenak sodu | 15307-79-6 | CEPGMPWC | CN | |
| Amlodypina bezylanu | 111470-99-6 | ASMFCEPGMP | CN/IN | |
| Apixaban | Anti-coagulant | 503612-47-3 | DMFWC | IND |
| Artemether | Anti-malarial | 71963-77-4 | IND | |
| Ciprofloksacyna HCl | 86393-32-0 | CEPGMPWC | CN/IN | |
| Artesunate Sodium | Anti-malarial | 82547-81-7 | IND | |
| Ramipril | 87333-19-5 | ASMFCEPGMP | IN/EU | |
| Atorvastatin Calcium | Anti-lipemic | 134523-00-5 | CEPDMFWC | IND |
| Simwastatyna | 79902-63-9 | ASMFCEPGMP | CN | |
| Atropine Sulfate | Anti-muscarinic agent | 5908-99-6 | CEPDMFWC | IND |
| Baricitinib under development | Anti-cancer | 1187594-09-7 | IND | |
| Bempedoic acid under development | Anti-lipemic | 738606-46-7 | IND | |
| Bilastine under development | Anti-histamine | 202189-78-4 | IND | |
| Bisoprolol Fumarate | Anti-hypertensive | 104344-23-2 | CEPDMFWC | IND |
| Brexpiprazole under development | Anti-depressant | 913611-97-9 | IND | |
| Brompheniramine maleate | Anti-histamine | 980-71-2 | CEPDMFWC | IND |
| Brinzolamide | Anti-cancer | 138890-62-7 | DMF | POL |
| Bupropion Hydrochloride | Smoking cessasion | 31677-93-7 | DMFWC | IND |
| Calcifediol monohydrate | Vitamin analogue | 63283-36-3 | CEPDMF | POL |
| Calcitriol | Vitamin analogue | 32222-06-3 | DMF | POL |
| Calcium L-5-Methyltetrahydrofolate | Vitamin | 151533-22-1 | DMFWC | IND |
| Candesartan Cilexetil | Angiotensin receptor blocker | 145040-37-5 | DMFWC | IND |
| Carglumic Acid | Hyperammonaemia | 1188-21-2 | DMF | ITA |
| Cariprazine HCl under development | Anti-psychotic (schizophrenia) | 1083076-69-0 | IND | |
| Carprofen | Anti-inflammatory | 53716-49-7 | DMF | ITA |
| Carvedilol | Cardiovascular | 72956-09-3 | DMF | POL |
| Celecoxib | NSAID | 169590-42-5 | DMFWC | IND |
| Cenobamate under development | Anti-convulsant | 913465-89-7 | IND | |
| Cetirizine Dihydrochloride | Anti-allergic | 83881-52-1 | DMFWC | IND |
| Cetirizine Hydrochloride | Anti-allergic | 83834-59-7 | DMFWC | IND |
| Chlophedianol Hydrochloride | Anti-tussive | 801-26-5 | DMF | ITA |
| Chloropyramine Hydrochloride | Anti-histamine | 6170-42-9 | DMF | ITA |
| Chlorpheniramine maleate | Anti-histamine | 113-92-8 | CEPDMFWC | IND |
| Chlorzoxazone | Muscle relaxant | 95-25-0 | DMFWC | IND |
| Chondroitin sulfate | Joint health | 9007-28-7 | CEPDMFWC | CHN |
| Cilostazol | Cardiovascular | 73963-72-1 | DMF | POL |
| Cinnarizine | Anti-histamine / anti-psychotic | 298-57-7 | CEPDMFWC | IND |
| Clindamycin hydrochloride | Anti-biotic | 21462-39-5 | CEPDMFWC | CHN |
| Clindamycin phosphate | Anti-biotic | 24729-96-2 | CEPDMFWC | CHN |
| Cloperastine Fendizoate under development | Decongestant | 85187-37-7 | IND | |
| Cloperastine Hydrochloride under development | Decongestant | 14984-68-0 | IND | |
| Clopidogrel | Anti-thrombotic | 113665-84-2 | DMFWC | IND |
| Clopidogrel | Anti-thrombotic | 113665-84-2 | DMF | POL |
| Colchicine | Anti-inflammatory / anti-gout | 64-86-8 | CEPDMF | IND |
| Colchicine | Anti-inflammatory / anti-gout | 64-86-8 | IND | |
| Cyanocobalamin | Vitamin | 68-19-9 | CEPDMF | CHN |
| Cycloserine | Anti-biotic | 68-41-7 | DMFWC | IND |
| Dalfampridine | Multiple sclerosis | 504-24-5 | DMF | ITA |
| Dapagliflozin Amorphous | Anti-diabetic | 461432-26-8 | DMFWC | IND |
| Dapagliflozin Propanediol | Anti-diabetic | 461432-26-8 | DMFWC | IND |
| Daprodustat under development | Anaemia | 808118-40-3 | IND | |
| Daridorexant under development | Anti-depressant | 1509154-09-3 | IND | |
| Diphenhydramine Hydrochloride | Anti-allergic | 147-24-0 | CEPDMFWC | IND |
| Desloratadine | Anti-histamine | 100643-71-8 | CEPDMFWC | IND |
| Dexbrompheniramine maleate | Anti-histamine | 149-64-4 | DMFWC | IND |
| Dexchlorpheniramine maleate | Anti-histamine | 2438-32-6 | DMFWC | IND |
| Dexketoprofen | NSAID | 22161-81-5 | DMFWC | IND |
| Dexrabeprazole | Anti-ulcer | 117976-94-0 | DMFWC | IND |
| Dextromethorphan Hydrobromide | Decongestant | 6700-34-1 | DMFWC | IND |
| Diclofenac Potassium | Anti-inflammatory | 15307-81-0 | CEPDMFWC | CHN |
| Diclofenac Sodium | Anti-inflammatory | 15307-79-6 | CEPDMFWC | CHN |
| Diethylcarbamazine Citrate | Anti-infection | 1642-73-3 | DMFWC | IND |
| Diltiazem hydrochloride | Cardiovascular | 33286-22-5 | CEPDMFWC | IND |
| Diphenhydramine Citrate | Anti-allergic | 886-77-1 | DMF | IND |
| Diphenhydramine Methyl Sulfate | Anti-allergic | 1756-18-9 | IND | |
| Disodium phosphate dodecahydrate | Mineral salt | 10039-32-4 | CEPDMF | ESP |
| Edoxaban Tosylate | Anti-coagulant | 480449-70-5 | DMFWC | IND |
| Efinaconazole | Anti-fungal | 164650-44-6 | DMF | ITA |
| Empagliflozin | Anti-diabetic | 864070-44-0 | DMFWC | IND |
| Enoxolone | Anti-inflammatory / anti-hypertensive | 471-53-4 | CEPDMF | JPN |
| Enzalutamide under development | Anti-cancer | 915087-33-1 | IND | |
| Ertugliflozin L-Pyroglutamate | Anti-diabetic | 1277399-25-7 | DMFWC | IND |
| Esketamine Hydrochloride | Analgesic / Anesthetic | 850-17-9 | CEPDMFWC | IND |
| Ethinylestradiol under development | Hormones | 57-63-6 | IND | |
| Etodolac | Anti-inflammatory / anti-rheumatic | 41340-25-4 | CEPDMFWC | IND |
| Etofylline | Hemorreologic agent | 519-37-9 | IND | |
| Etoricoxib under development | Anti-inflammatory | 202409-33-4 | IND | |
| Febuxostat | Anti-gout | 144060-53-7 | DMFWC | IND |
| Felbamate | Anti-epileptic | 25451-15-4 | DMF | ITA |
| Fexofenadine Hydrochloride | Anti-histamine | 153439-40-8 | CEPDMFWC | IND |
| Finerenone under development | Chronic kidney disease | 1050477-31-0 | IND | |
| Flunarizine dihydrochloride | Anti-vertigo | 30484-77-6 | CEPDMFWC | IND |
| Fluralaner under development | Veterinary API | 864731-61-3 | IND | |
| Furosemide | Diuretic | 54-31-9 | CEPDMFWC | IND |
| Gadopiclenol under development | Contrast media | 933983-75-6 | IND | |
| Gadobutrol under development | Contrast media | 138071-82-6 | IND | |
| Glucosamine hydrochloride | Joint health | 66-84-2 | DMFWC | IND |
| Glucosamine sulfate potassium salt | Joint health | 31284-96-5 | DMFWC | IND |
| Glucosamine sulfate sodium salt | Joint health | 38899-05-7 | DMFWC | IND |
| Glycopyrrolate | Anti-ulcer | 596-51-0 | CEPDMF | IND |
| Granisetron | Anti-nausea | 109889-09-0 | CEPDMF | IND |
| Grapiprant under development | Veterinary API | 415903-37-6 | IND | |
| Guanfacine Hydrochloride | ADHD | 29110-48-3 | DMF | ITA |
| Homatropine | Anti-cholinergic | 51-55-8 | DMFWC | IND |
| Hydroxychloroquine sulfate | Anti-malarial / Anti-rheumatic | 747-36-4 | CEPDMF | IND |
| Hydroxycobalamin | Vitamin | 13422-51-0 | DMFWC | IND |
| Hydroxycobalamin Acetate | Vitamin | 22465-48-5 | DMFWC | IND |
| Hydroxycobalamin Hydrochloride | Vitamin | 58288-50-9 | DMFWC | IND |
| Hydroxycobalamin Sulfate | Vitamin | – | DMFWC | IND |
| Hydroxyzine hydrochloride | Anti-histamine / anti-anxiety | 2192-20-3 | CEPDMFWC | IND |
| Ibandronate sodium monohydrate | Osteoporosis | 138844-81-2 | CEPDMFWC | IND |
| Ibrutinib under development | Anti-cancer | 936563-96-1 | IND | |
| Iloperidone | Anti-psychotic (schizophrenia) | 133454-47-4 | DMF | ITA |
| Imatinib mesylate | Anti-cancer | 220127-57-1 | DMF | POL |
| Ipratropium bromide | Anti-cholinergic | 22254-24-6 | CEPDMFWC | IND |
| Isopropamide Iodide | Anti-spasmodic | 71-81-8 | DMF | ITA |
| Ketamine Hydrochloride | Analgesic / Anesthetic | 1867-66-9 | CEPDMFWC | IND |
| Ketoprofen | NSAID | 22071-15-4 | CEPDMFWC | IND |
| Ketorolac | NSAID | 74103-06-3 | DMFWC | IND |
| Labetalol Hydrochloride | Anti-hypertensive | 32780-64-6 | DMF | ITA |
| Landiolol Hydrochloride | Anti-arrythmic | 144481-29-6 | DMF | ITA |
| Latanoprost | Anti-cancer | 130209-82-4 | DMF | POL |
| Levocetirizine Dihydrochloride | Anti-histamine | 130018-77-8 | IND | |
| Levofloxacin hemihydrate | Anti-biotic | 138199-71-0 | CEPDMFWC | IND |
| Levosalbutamol Sulfate | Anti-asthmatic | 148919-94-6 | DMFWC | IND |
| Levosulpiride | Anti-psychotic | 23672-07-3 | DMF | ITA |
| Lidocaine base | local anesthetic agent | 137-58-6 | IND | |
| Lidocaine base | local anesthetic agent | 137-58-6 | CEPDMF | IND |
| Lidocaine HCL | local anesthetic agent | 73-78-9 | IND | |
| Linagliptin | Anti-diabetic | 668270-12-0 | DMFWC | IND |
| Liraglutide under development | Anti-diabetic / Obesity | 204656-20-2 | IND | |
| Lisdexamfetamine under development | ADHD | 608137-32-2 | IND | |
| Lobeline Hydrochloride under development | Smoking cessasion | 134-63-4 | IND | |
| Lofexidine | Opiod use disorder | 31036-80-3 | DMF | ITA |
| Loperamide hydrochloride | Anti-inflammatory / anti-diarrhea | 34552-83-5 | CEPDMFWC | IND |
| Loratadine | Anti-histamine | 79794-75-5 | CEPDMFWC | IND |
| Loxoprofen | NSAID | 68767-14-6 | DMFWC | IND |
| Lumefantrine | Anti-malarial | 82186-77-4 | IND | |
| Lurasidone Hydrochloride | Anti-psychotic (schizophrenia) | 367514-87-2 | DMF | ITA |
| Magnesium acetate tetrahydrate | Mineral salt | 16674-78-5 | CEPDMF | ESP |
| Maropitant | Anti-emetic | 147116-68-7 | DMF | ITA |
| Maropitant Citrate MonoHydrate | Anti-emetic | 359875-09-5 | DMF | ITA |
| Mavacamten under development | Cardiovascular | 1642288-47-8 | IND | |
| Meclozine dihydrochloride | Anti-histamine | 1104-76-5 | CEPDMFWC | IND |
| Melatonin | Hormones / sleeping aid | 73-31-4 | DMF | IND |
| Meloxicam | NSAID | 71125-38-7 | CEPDMF | IND |
| Memantine Hydrochloride | Alzheimer | 41100-52-1 | DMF | ITA |
| Mepyramine maleate | Anti-histamine | 59-33-6 | CEPDMFWC | IND |
| Methoxyphenamine Hydrochloride | Bronchodilator | 5588-10-3 | DMF | ITA |
| Methylcobalamin | Vitamin | 13422-55-4 | DMFWC | IND |
| Midostaurin | Anti-cancer (leukemia) | 120685-11-2 | DMF | ITA |
| Minodronic Acid Hydrate | Osteoporosis | 155648-60-5 | DMF | ITA |
| Montelukast Sodium | Anti-asthmatic | 151767-02-1 | CEPDMFWC | IND |
| Naftidrofuryl Oxalate | Vasodilator | 3200-06-4 | DMF | ITA |
| Naftopidil | Prostate | 57149-07-2 | DMF | ITA |
| Nalfurafine Hydrochloride | Anti-prutinic | 217974-28-2 | DMF | ITA |
| Neomycin Sulfate | Anti-biotic | 1405-10-3 | CEPDMFWC | CHN |
| Nicorandil | Anti-hypertensive | 65141-46-0 | DMFWC | IND |
| Nicotine | Smoking cessasion | 54-11-5 | DMF | IND |
| Nimesulide | NSAID | 51803-78-2 | CEPDMF | IND |
| Nitrendipine | Anti-hypertensive | 13099-74-8 | DMF | POL |
| Nitrofurantoin | Anti-biotic | 67-20-9 | CEPDMF | IND |
| Norethisterone under development | Hormones | 68-22-4 | IND | |
| Oclacitinib under development | Veterinary API | 1208319-26-6 | IND | |
| Olanzapine | Anti-psychotic | 132539-06-1 | DMF | POL |
| Olmesartan Medoxomil | Anti-Hypertensive | 144689-63-4 | DMFWC | IND |
| Omaveloxolone under development | Anti-ataxia | 1474034-05-3 | IND | |
| Orphenadrine Citrate | Anti-histamine | 4682-36-4 | DMF | ITA |
| Orphenadrine Hydrochloride | Anti-parkinson | 341-69-5 | DMF | ITA |
| Papaverine Hydrochloride | Anti-spasmodic | 61-25-6 | DMFWC | IND |
| Paricalcitol | Vitamin analogue | 131918-61-1 | DMF | POL |
| Penicillamine | Anti-inflammatory / anti-rheumatic | 52-67-5 | CEPDMFWC | IND |
| Pentazocine under development | Anti-inflammatory | 359-83-1 | IND | |
| Pentobarbital sodium under development | Anti-depressant | 57-33-0 | IND | |
| Pentosan Polysulfate | Anti-inflammation | 37319-17-8 | DMF | IND |
| Pentoxifylline | Hemorreologic agent | 6493-05-6 | CEPDMFWC | IND |
| Perazine Dimaleate | Anti-psychotic | 84-02-6 | DMFWC | IND |
| Phenelzine Sulfate | Anti-depressant | 156-12-7 | DMF | ITA |
| Pheniramine maleate | Anti-histamine | 132-20-7 | CEPDMFWC | IND |
| Phenylephrine Hydrochloride | Decongestant | 61-76-7 | IND | |
| Pirfenidone | Idiopathic pulmonary fibrosis | 53179-13-8 | DMF | ITA |
| Ractopamine Hydrochloride | 90274-24-1 | IND | ||
| Potassium acetate | Mineral salt | 127-08-2 | CEPDMF | ESP |
| Pregabalin | Anti-convulsant | 148553-50-8 | CEPDMF | IND |
| Pregabalin | Anti-convulsant | 148553-50-8 | DMFWC | IND |
| Prilocaine | local anesthetic agent | 721-50-6 | CEPDMF | IND |
| Propafenone Hydrochloride | Anti-arrythmic | 34183-22-7 | DMF | ITA |
| Protamine Sulfate | Neutralisation of heparin action | 53597-25-4 | DMF | JPN |
| Pyridostigmine Bromide | Anti-myasthenics | 101-26-8 | CEPDMF | ITA |
| Pyrilamine Maleate | Anti-histamine | 59-33-6 | DMFWC | IND |
| Quinine Sulfate | Anti-malarial | 6119-70-6 | DMFWC | IND |
| Rebamipide | Anti-ulcer | 90098-04-7 | DMFWC | IND |
| Riboflavin Sodium Phosphate | Vitamin | 130-40-5 | CEPDMFWC | IND |
| Rimegepant sulfate | Anti-migraine | 1374024-48-2 | DMFWC | IND |
| Riociguat under development | Pulmonary heart failure | 625115-55-1 | IND | |
| Risedronate sodium | Osteoporosis | 115436-72-1 | CEPDMFWC | IND |
| Rivaroxaban | Anti-coagulant | 366789-02-8 | CEPDMFWC | IND |
| Rosuvastatin Calcium Amorphous | Anti-lipemic | 147098-20-2 | CEPDMFWC | IND |
| Rosuvastatin Calcium Crystalline | Anti-lipemic | 147098-20-2 | CEPDMFWC | IND |
| Rutoside trihydrate | Anti-oxidant | 6151-73-9 | CEPDMF | JPN |
| Ruxolitinib under development | Anti-cancer | 941678-49-5 | IND | |
| Salbutamol Sulphate | Anti-asthmatic | 51022-70-9 | CEPDMFWC | IND |
| Saxagliptin Hydrochloride | Anti-diabetic | 709031-78-7 | DMFWC | IND |
| Saxagliptin Hydrochloride Dihydrate | Anti-diabetic | 1073057-20-1 | DMFWC | IND |
| Semaglutide under development | Anti-diabetic / Obesity | 910463-68-2 | IND | |
| Silodosin | Anti-edema (prostate) | 160970-54-7 | DMF | IND |
| Sitagliptin Phosphate Anhydrous | Anti-diabetic | 654671-77-9 | DMFWC | IND |
| Sitagliptin Phosphate Monohydrate | Anti-diabetic | 654671-78-0 | CEPDMFWC | IND |
| Sodium acetate trihydrate | Mineral salt | 6131-90-4 | CEPDMF | ESP |
| Sodium dihydrogen phosphate dihydrate | Mineral salt | 13472-35-0 | CEPDMF | ESP |
| Sodium fluoride | Mineral salt | 7681-49-4 | CEPDMF | ESP |
| Sodium hyaluronate | Joint health / opthalmology | 9067-32-7 | CEPDMFWC | CHN |
| Streptokinase / Streptodornase | Enzyme / anti-inflammatory | 9004-07-3 / 9026-00-0 | DMFWC | KOR |
| Sulfadoxine | Anti-malarial | 2447-57-6 | CEPDMF | IND |
| Tacalcitol | Vitamin analogue | 57333-96-7 | CEPDMF | POL |
| Tafamidis under development | CNS Agent | 594839-88-0 | IND | |
| Tafamidis Meglumine under development | CNS Agent | 951395-08-7 | IND | |
| Tamsulosin | Anti-inflammatory (prostate) | 106133-20-4 | CEPDMF | IND |
| Tapentadol under development | Analgesic | 175591-23-8 | IND | |
| Theobromine | Cardiovascular | 83-67-0 | DMFWC | IND |
| Thio-Colchicine | Anti-inflammatory / anti-gout | 2730-71-4 | IND | |
| Thiocolchicoside | Anti-inflammatory | 602-41-5 | CEPDMF | IND |
| Thioctic Acid | Anti-oxidant | 1077-28-7 | DMFWC | IND |
| Ticagrelor under development | Anti-platelet (prevention of stroke & heart attack) | 274693-27-5 | IND | |
| Tigecycline under development | Anti-biotic | 220620-09-7 | IND | |
| Tofacitinib Citrate under development | Anti-cancer | 540737-29-9 | IND | |
| Tramadol Hydrochloride | Analgesic / Anesthetic | 22204-91-7 | DMFWC | IND |
| Trelagliptin Succinate under development | Anti-diabetic | 1029877-94-8 | IND | |
| Trifluridine | Anti-viral | 70-00-8 | DMF | ITA |
| Trospium Chloride | Overactive bladder | 10405-02-4 | DMF | ITA |
| Vericiguat under development | Systolic heart failure | 1350653-20-1 | IND | |
| Vildagliptin | Anti-diabetic | 274901-16-5 | DMFWC | IND |
| Vinpocetine | Brain function | 42971-09-5 | DMF | IND |
| Vonoprazan Fumarate | Anti-ulcer | 881681-01-2 | DMFWC | IND |
| Vortioxetine Hydrobromide | Anti-depressant | 960203-27-4 | DMFWC | IND |
| Zavegepant under development | Anti-migraine | 1337918-83-8 | IND | |
| Zinc acetate dihydrate | Mineral salt | 5970-45-6 | CEPDMF | ESP |
If the substance you are looking for is not on the list, get in touch.
Support at every stage
Quality and regulatory compliance
We hold the certificates and authorisations required to import and distribute active substances under Polish pharmaceutical law and Good Distribution Practice (GDP). Our procedures are designed to ensure the quality, safety and traceability of active substances at every stage of the supply chain.
A broad portfolio and a flexible approach
Our range covers active substances used in many therapeutic areas. Working with manufacturers from many regions of the world, we can find solutions tailored to each Client’s needs – in terms of quality and regulatory parameters as well as availability and continuity of supply.
We understand that for pharmaceutical manufacturers what matters is not only the quality of the API itself, but also predictable deliveries, a secure source and smooth communication throughout the cooperation. That is why we focus on long-term relationships with suppliers and Clients, a transparent process and an individual approach to every project.
A secure API supply chain
The security and quality of the supply chain are the foundation of our business. We monitor our cooperation with qualified manufacturers and apply procedures designed to reduce the risks associated with the supply of active substances. We pay particular attention to compliance of deliveries with the agreed quality requirements, proper transport and storage conditions, and full traceability of the process.
Ask about an active substance
If you are looking for a proven API supplier, please get in touch.
We will prepare a solution tailored to your individual quality, regulatory and purchasing requirements.